Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-K Filing
FORT COLLINS, Colo., April 22, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma (NASDAQ:STAB) (the "Company"), a biopharmaceutical company creating next-generation immune ...